Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 15, 2025 08:30 ET | Source: Actinogen Medical

Actinogen achieves agreement with the FDA in a Type C meeting on the manufacturing, clinical and nonclinical activities required for a future US marketing approval of Xanamem for Alzheimer’s disease

SYDNEY, Sept. 15, 2025 (GLOBE NEWSWIRE) -- Actinogen Medical Limited (ASX: ACW) announces the successful conduct of its scheduled Type C meeting (written response) on Alzheimer’s disease (AD) with...
August 19, 2025 09:31 ET | Source: Rendever

Rendever Rolls Out Immersive Dementia Simulation and Empathy Training for Improved Caregiving & Societal Understanding

BOSTON, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Rendever, the company leading the industry in immersive technology for aging, has launched a cutting-edge dementia and empathy training program for senior...
July 07, 2025 08:00 ET | Source: Posit Science

Novel Digital Test Provides Revolutionary Tool to Assess Brain Chemistry

SAN FRANCISCO, July 07, 2025 (GLOBE NEWSWIRE) -- For the first time, a study shows a digital assessment can provide a scientific measure of acetylcholine – a key brain chemical whose decline signals...
June 12, 2025 04:42 ET | Source: Research and Markets

Psychiatry Collaboration and Licensing Deals Directory 2025: New Report Analyzes 569 Psychiatry Licensing & Collaboration Deals from 2019-2025

Dublin, June 12, 2025 (GLOBE NEWSWIRE) -- The "Psychiatry Collaboration and Licensing Deals 2019-2025" report has been added to ResearchAndMarkets.com's offering.Psychiatry Collaboration and...
June 04, 2025 11:58 ET | Source: LifeLabs

LifeLabs Introduces Three Blood-Based Alzheimer’s Disease Tests, Including Support Services

Toronto, Ontario, June 04, 2025 (GLOBE NEWSWIRE) -- LifeLabs, a leading provider of health diagnostics and laboratory services, is proud to announce the launch of a comprehensive portfolio of...
May 01, 2025 08:00 ET | Source: Neurogen Biomarking

Neurogen Announces Partnership with NeuroX, a subsidiary of American TelePhysicians

Neurogen Announces Partnership with NeuroX, a subsidiary of American TelePhysicians
February 12, 2025 07:46 ET | Source: Research and Markets

Cognitive Diagnostics Market Trends and Growth Forecast, 2025-2030 - Strategic Partnerships and Investments in Innovative Testing Driving Revenues, Exceeding $195 Billion in 2030

Dublin, Feb. 12, 2025 (GLOBE NEWSWIRE) -- The "Cognitive Diagnostics Market - Forecasts from 2025 to 2030" report has been added to ResearchAndMarkets.com's offering.The cognitive diagnostics...
January 21, 2025 08:00 ET | Source: Posit Science

Hundreds of Studies Show Efficacy of One Particular Brain Fitness Program

SAN FRANCISCO, Jan. 21, 2025 (GLOBE NEWSWIRE) -- New data from papers published in science and medical journals in 2024 shows tremendous growth in the evidence of efficacy of one particular brain...
November 25, 2024 21:01 ET | Source: NeuroAge Therapeutics

NeuroAge Therapeutics: Revolutionary Brain Health Test Predicts Dementia Risk 30 Years in Advance

NeuroAge Therapeutics launches the NeuroAge Test, a cutting-edge tool predicting dementia risk 30 years early to optimize brain health
November 08, 2024 12:29 ET | Source: Internal Healthcare

Internal Healthcare Group Launches as a Comprehensive Referral Platform for Senior Care Services Across the U.S. and Australia

TAMPA, Fla., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Internal Healthcare Group, a newly founded senior referral service, is excited to announce its virtual launch, introducing a unique approach to...